Loading company…
PredicTx Health uses CT-based body analysis to support personalized chemotherapy dosing.
Founded in 2025 and based in Melbourne, Australia, PredicTx Health develops a precision oncology platform that analyzes CT scans to profile body composition and inform chemotherapy dosing. It serves oncologists and healthcare institutions. In October 2025, the company received grant funding from Australia's Economic Accelerator and Victorian Department of Health as part of a larger USD 1.6 million angel and grant funding round.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in